Search results
Results from the WOW.Com Content Network
Academic health centers, which emphasize research, teaching, and new technologies, may be disadvantaged by the payment scheme. [59] Providers risk large losses, for example if a patient experiences a catastrophic event. [60] A complex "reinsurance mechanism" may be needed to convince providers to accept bundled payments. [60]
The World Health Organization and Health Action International (WHO/HAI) made a conjoint effort to systematize the methodology of medicine price surveys and ERP usage, first publishing the WHO/HAI methodology in manual in 2003, [3]: 195 which is frequently used in price studies in unregulated prices context often found in low and moderate income ...
The Healthcare Cost and Utilization Project (HCUP, pronounced "H-Cup") is a family of healthcare databases and related software tools and products from the United States that is developed through a Federal-State-Industry partnership and sponsored by the Agency for Healthcare Research and Quality (AHRQ).
health care competition to the economy and consumer welfare, anticompetitive conduct in health care markets has long been a key target of FTC law enforcement,6 research,7 and advocacy.8 Of particular relevance to our analysis of A-5502-B is the Commission’s 2005 “Conflict of Interest Study” regarding pharmacy benefit managers (“PBMs”).
[9] [10] [11] Government mandated critical care and government insurance programs like Medicare also impact the market pricing of U.S. health care. According to The New York Times in 2011, "the United States is far and away the world leader in medical spending, even though numerous studies have concluded that Americans do not get better care ...
Medication costs can be the selling price from the manufacturer, that price together with shipping, the wholesale price, the retail price, and the dispensed price. [3]The dispensed price or prescription cost is defined as a cost which the patient has to pay to get medicines or treatments which are written as directions on prescription by a prescribers. [4]
Internal reference pricing may reduce expenditures in the short term by incentivizing people to use the reference drugs at the reference price, but the effect on drugs with a higher price than reference and on health is uncertain. [26] [29] Some countries, such as Denmark which has a long history of using ERP, switched to internal reference ...
It is maintained by Management Sciences for Health (MSH) on behalf of the World Health Organization. [1] The guide has been published annually since 1986 with the World Health Organization becoming involved in 2000, [2] [3] though has not been updated since 2015. [4] The prices in the guide are specifically for low and middle income countries ...